دورية أكاديمية
أعرض في EDS

Perspective vaccines for emerging viral diseases in farm animals.

التفاصيل البيبلوغرافية
العنوان: Perspective vaccines for emerging viral diseases in farm animals.
المؤلفون: Allam AM; Parasitology and Animal Diseases Department, Veterinary Research Institute, National Research Centre, Cairo, Egypt., Elbayoumy MK; Parasitology and Animal Diseases Department, Veterinary Research Institute, National Research Centre, Cairo, Egypt., Ghazy AA; Parasitology and Animal Diseases Department, Veterinary Research Institute, National Research Centre, Cairo, Egypt.
المصدر: Clinical and experimental vaccine research [Clin Exp Vaccine Res] 2023 Jul; Vol. 12 (3), pp. 179-192. Date of Electronic Publication: 2023 Jul 31.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Korean Vaccine Society Country of Publication: Korea (South) NLM ID: 101592344 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2287-3651 (Print) Linking ISSN: 22873651 NLM ISO Abbreviation: Clin Exp Vaccine Res Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Seoul : Korean Vaccine Society
مستخلص: The world has watched the emergence of numerous animal viruses that may threaten animal health which were added to the perpetual growing list of animal pathogens. This emergence drew the attention of the experts and animal health groups to the fact that it has become necessary to work on vaccine development. The current review aims to explore the perspective vaccines for emerging viral diseases in farm animals. This aim was fulfilled by focusing on modern technologies as well as next generation vaccines that have been introduced in the field of vaccines, either in clinical developments pending approval, or have already come to light and have been applied to animals with acceptable results such as viral-vectored vaccines, virus-like particles, and messenger RNA-based platforms. Besides, it shed the light on the importance of differentiation of infected from vaccinated animals technology in eradication programs of emerging viral diseases. The new science of nanomaterials was explored to elucidate its role in vaccinology. Finally, the role of Bioinformatics or Vaccinomics and its assist in vaccine designing and developments were discussed. The reviewing of the published manuscripts concluded that the use of conventional vaccines is considered an out-of-date approach in eliminating emerging diseases. However, these types of vaccines are considered the suitable plan especially in countries with few resources and capabilities. Piloted vaccines that rely on genetic-based technologies with continuous analyses of current viruses should be the aim of future vaccinology. Smart genomics of emerging viruses will be the gateway to choosing appropriate vaccines, regardless of the evolutionary rates of viruses.
Competing Interests: No potential conflict of interest relevant to this article was reported.
(© Korean Vaccine Society.)
References: PLoS One. 2014 Jun 19;9(6):e100392. (PMID: 24945377)
J Gen Virol. 1995 Dec;76 ( Pt 12):3089-98. (PMID: 8847514)
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12283-7. (PMID: 25136134)
Biotechnol Lett. 2009 Aug;31(8):1159-65. (PMID: 19343503)
Curr Opin Biotechnol. 2013 Dec;24(6):1159-66. (PMID: 23578464)
Arch Virol. 2017 Feb;162(2):359-367. (PMID: 27757685)
J Invertebr Pathol. 2011 Jul;107 Suppl:S42-8. (PMID: 21784230)
Cell Rep Med. 2020 Jun 23;1(3):100040. (PMID: 32835303)
Vaccine. 1996 Apr;14(5):419-27. (PMID: 8735554)
Front Immunol. 2018 Mar 02;9:325. (PMID: 29599766)
Curr Treat Options Allergy. 2015;2(1):72-82. (PMID: 25722959)
Vaccine. 2012 Mar 9;30(12):2131-9. (PMID: 22285887)
Clin Exp Vaccine Res. 2017 Jul;6(2):72-82. (PMID: 28775971)
Gene Ther. 2021 Apr;28(3-4):117-129. (PMID: 33093657)
Acta Biomater. 2020 May;108:1-21. (PMID: 32268235)
Virology. 2009 Mar 15;385(2):409-15. (PMID: 19157482)
Anim Health Res Rev. 2019 Dec;20(2):143-162. (PMID: 32081122)
Pol J Vet Sci. 2011;14(2):299-304. (PMID: 21721420)
Mol Pharm. 2020 Dec 7;17(12):4407-4420. (PMID: 33147978)
Arch Virol. 2019 Jun;164(6):1501-1513. (PMID: 30888563)
Virology. 2021 May;557:70-85. (PMID: 33676349)
Science. 2000 Mar 10;287(5459):1816-20. (PMID: 10710308)
J Virol. 2015 Aug;89(16):8267-79. (PMID: 26041279)
Vaccine. 2010 Mar 8;28(11):2271-6. (PMID: 20079874)
J Hum Virol. 2000 Mar-Apr;3(2):63-76. (PMID: 10850891)
Int J Nanomedicine. 2014 Dec 02;9:5603-18. (PMID: 25506214)
Immunity. 2010 Oct 29;33(4):530-41. (PMID: 21029963)
Clin Vaccine Immunol. 2013 Aug;20(8):1115-22. (PMID: 23720365)
Vaccine. 2010 Apr 19;28(18):3159-70. (PMID: 20189484)
Vaccine. 2014 Nov 20;32(49):6614-21. (PMID: 25312275)
Wkly Epidemiol Rec. 2016 Mar 25;91(12):145-68. (PMID: 27039410)
Sci Rep. 2018 Feb 14;8(1):3021. (PMID: 29445124)
Methods. 2006 Sep;40(1):60-5. (PMID: 16997714)
Vaccine. 2010 May 7;28(21):3722-34. (PMID: 20307593)
Vet World. 2020 Jan;13(1):1-9. (PMID: 32158144)
Vaccine. 2008 Mar 10;26(11):1471-81. (PMID: 18289743)
Viruses. 2014 Jun 25;6(7):2531-50. (PMID: 24967693)
J Comp Pathol. 2009 Jul;141(1):1-16. (PMID: 19476953)
Front Immunol. 2020 Aug 27;11:2074. (PMID: 33042118)
Bioconjug Chem. 2011 Mar 16;22(3):346-52. (PMID: 21338097)
Vaccine. 2007 Jan 8;25(4):672-8. (PMID: 17059856)
Res Vet Sci. 2014 Jun;96(3):551-7. (PMID: 24726021)
Nanoscale. 2014 Jun 21;6(12):6617-26. (PMID: 24811899)
Vaccine. 2007 Sep 17;25(37-38):6774-83. (PMID: 17669563)
Nat Rev Drug Discov. 2018 Apr;17(4):261-279. (PMID: 29326426)
Viruses. 2020 Apr 27;12(5):. (PMID: 32349216)
N Biotechnol. 2017 Oct 25;39(Pt B):174-180. (PMID: 28778817)
Vaccines (Basel). 2021 Jan 13;9(1):. (PMID: 33451136)
Clin Exp Vaccine Res. 2013 Jul;2(2):97-105. (PMID: 23858400)
J Med Virol. 2020 Apr;92(4):418-423. (PMID: 31967327)
Acta Biomater. 2019 Dec;100:326-337. (PMID: 31610342)
BMC Vet Res. 2015 Aug 21;11:220. (PMID: 26293453)
Res Vet Sci. 2016 Feb;104:181-7. (PMID: 26850558)
Mol Biotechnol. 2013 Jan;53(1):92-107. (PMID: 23001867)
J Vet Res. 2020 Nov 06;64(4):487-493. (PMID: 33367136)
Vaccine. 2005 Jan 26;23(10):1242-50. (PMID: 15652666)
Front Bioeng Biotechnol. 2020 Dec 11;8:608050. (PMID: 33363134)
Vaccines (Basel). 2020 Nov 13;8(4):. (PMID: 33202961)
Vaccines (Basel). 2021 Jan 28;9(2):. (PMID: 33525396)
Biomater Res. 2019 Nov 21;23:20. (PMID: 31832232)
J Vet Med Sci. 1997 May;59(5):311-22. (PMID: 9192350)
Vet Microbiol. 2009 May 28;137(1-2):10-7. (PMID: 19167843)
Adv Mater. 2021 Nov;33(47):e2005927. (PMID: 33586180)
Vaccines (Basel). 2020 May 18;8(2):. (PMID: 32443437)
Nat Biotechnol. 2006 Nov;24(11):1377-83. (PMID: 17093488)
J Virol. 1991 Dec;65(12):6572-80. (PMID: 1658362)
BMC Biotechnol. 2007 Sep 27;7:62. (PMID: 17900346)
Expert Rev Vaccines. 2011 Jul;10(7):1063-81. (PMID: 21806400)
Nat Rev Immunol. 2010 Nov;10(11):787-96. (PMID: 20948547)
Signal Transduct Target Ther. 2020 Oct 13;5(1):237. (PMID: 33051445)
Transbound Emerg Dis. 2015 Aug;62(4):367-87. (PMID: 24112127)
J Immunol. 2007 Feb 15;178(4):2361-9. (PMID: 17277142)
Berl Munch Tierarztl Wochenschr. 2003 May-Jun;116(5-6):183-91. (PMID: 12784550)
Inflamm Regen. 2020 Aug 10;40:17. (PMID: 32834891)
Clin Exp Vaccine Res. 2020 Jul;9(2):119-125. (PMID: 32864368)
Vaccine. 2002 Feb 22;20(11-12):1631-9. (PMID: 11858872)
Nat Biotechnol. 2012 Dec;30(12):1210-6. (PMID: 23159882)
Emerg Infect Dis. 2001;7(3 Suppl):494-6. (PMID: 11485640)
فهرسة مساهمة: Keywords: Computational biology; Nanoparticle drug delivery system; Synthetic vaccines; Vaccines; Virus-like particle vaccines; mRNA vaccine
تواريخ الأحداث: Date Created: 20230821 Latest Revision: 20230823
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC10435774
DOI: 10.7774/cevr.2023.12.3.179
PMID: 37599803
قاعدة البيانات: MEDLINE
الوصف
تدمد:2287-3651
DOI:10.7774/cevr.2023.12.3.179